HeiQ will transition to trading on the JP Jenkins securities platform or a similar matching system starting 20 November.
The Swiss-based company's board unanimously approved the decision to privatise, marking the end of its four-year run as a public entity.
"Our four years as a public company have seen us acquire four companies and change from a yield-focused speciality chemicals player with a narrow textile focus to a multi-technology platform innovation incubator with diversified market channels and long-term value creation opportunities," explained Carlo Centonze, co-founder and group CEO of HeiQ.
Since its December 2020 listing, the firm has evolved from a textile-focused speciality chemicals company into a multi-platform technology venture incubator.
During its time as a public company, the firm expanded into four new technology areas including precision fermentation, cellulosic fibre extrusion, particle synthesis and chemical vapour deposition.
The privatisation move aims to provide greater flexibility in funding and developing the company's key ventures, such as HeiQ Synbio, HeiQ AeoniQ, HeiQ GrapheneX, and HeiQ Xpectra.
The company said it maintains its commitment to its core business segments of value-adding textile technologies and Synbiotics for cleaning and personal care.
The innovator company’s global partnerships in textile finishing remain a vital part of its strategy, as the company leads the way in solutions that benefit industries and consumers worldwide.
The company will continue operations in these sectors while pursuing the development of its emerging technology platforms.
